Complicated urinary tract infection in adults.

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMC 2094997)

Published in Can J Infect Dis Med Microbiol on November 01, 2005

Authors

L E Nicolle, AMMI Canada Guidelines Committee*

Articles citing this

Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial. BMC Med (2010) 1.77

NXL104 irreversibly inhibits the β-lactamase from Mycobacterium tuberculosis. Biochemistry (2012) 0.98

Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect Immun (2013) 0.93

Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection. Antimicrob Agents Chemother (2013) 0.87

Renal abscess caused by a Providencia stuartii isolate biochemically misidentified as Pasteurella. J Clin Microbiol (2013) 0.83

Management of the complications of BPH/BOO. Indian J Urol (2014) 0.83

Microbial biofilm formation and catheter-associated bacteriuria in patients with suprapubic catheterisation. World J Urol (2012) 0.82

Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial. J Korean Med Sci (2012) 0.82

Retrospective study for risk factors for febrile UTI in spinal cord injury patients with routine concomitant intermittent catheterization in outpatient settings. Spinal Cord (2015) 0.82

Extended-spectrum beta-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: Urologist should act in time. Urol Ann (2014) 0.80

Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study. BMC Infect Dis (2014) 0.80

The role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients. Clin J Am Soc Nephrol (2010) 0.77

Urinary Tract Infections: Leading Initiatives in Selecting Empiric Outpatient Treatment (UTILISE). Can J Hosp Pharm (2014) 0.77

WHO/INRUD prescribing indicators and prescribing trends of antibiotics in the Accident and Emergency Department of Bahawal Victoria Hospital, Pakistan. Springerplus (2016) 0.77

Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections. BMC Infect Dis (2016) 0.76

Value of an aggregate index in describing the impact of trends in antimicrobial resistance for Escherichia coli. Can J Infect Dis Med Microbiol (2015) 0.76

Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey. Can Urol Assoc J (2014) 0.76

Genitourinary infection in diabetes. Indian J Endocrinol Metab (2013) 0.75

Antimicrobial resistance in community-acquired Escherichia coli isolated from urinary infection: Good news or bad? Can J Infect Dis Med Microbiol (2013) 0.75

Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women. Antimicrob Agents Chemother (2015) 0.75

Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodology. Antimicrob Resist Infect Control (2017) 0.75

[Candiduria! What now? : Therapy of urinary tract infections with Candida]. Urologe A (2017) 0.75

Antibiotic Resistance and Virulence Phenotypes of Recent Bacterial Strains Isolated from Urinary Tract Infections in Elderly Patients with Prostatic Disease. Pathogens (2017) 0.75

Differential characteristics of healthcare-associated compared to community-acquired febrile urinary tract infections in males. Eur J Clin Microbiol Infect Dis (2015) 0.75

Articles cited by this

(truncated to the top 100)

Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev (2002) 17.58

Infection in organ-transplant recipients. N Engl J Med (1998) 6.49

Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am (1997) 5.27

Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 4.20

Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med (2002) 4.09

Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med (1991) 2.91

Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med (1987) 2.48

A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury. Clin Infect Dis (2004) 2.29

Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women? Ann Intern Med (1994) 2.26

Bacteriuria in elderly institutionalized men. N Engl J Med (1983) 2.20

Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med (1989) 2.17

Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 2.15

Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. Clin Infect Dis (1996) 2.12

Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Ann Intern Med (1995) 2.03

Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med (1984) 1.85

Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am (1997) 1.83

Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 1.80

Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil (2002) 1.60

Prevention of nosocomial urinary tract infection in ICU patients: comparison of effectiveness of two urinary drainage systems. Chest (2001) 1.56

Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis (2000) 1.52

Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehabil (1995) 1.51

Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am (1997) 1.51

Febrile urinary infection in the institutionalized elderly. Am J Med (1996) 1.47

A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med (1995) 1.33

Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med (1999) 1.28

Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. Working Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of America. J Infect Dis (1992) 1.28

Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J Infect Dis (1990) 1.21

Therapy vs no therapy for bacteriuria in elderly ambulatory nonhospitalized women. JAMA (1987) 1.19

A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med (1990) 1.17

How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study. Ann Intern Med (1991) 1.15

Renal stones and urinary infection: a study of antibiotic treatment. Br Med J (1976) 1.15

Differences in urinary tract infections in male and female spinal cord injury patients on intermittent catheterization. Paraplegia (1995) 1.10

Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA (1982) 1.08

Prevention of catheter-associated urinary tract infections. Efficacy of daily meatal care regimens. Am J Med (1981) 1.05

Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder. J Urol (1987) 1.05

The chronic indwelling catheter and urinary infection in long-term-care facility residents. Infect Control Hosp Epidemiol (2001) 1.05

Antibiotics for the prevention of septicaemia in urology. J Antimicrob Chemother (1982) 1.04

A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection. Urology (1998) 1.02

Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med (1993) 1.01

Catheter-associated bacteriuria. Failure to reduce attack rates using periodic instillations of a disinfectant into urinary drainage systems. JAMA (1984) 1.01

Evaluation of daily meatal care with poly-antibiotic ointment in prevention of urinary catheter-associated bacteriuria. J Urol (1983) 0.99

Renal and perirenal abscesses. Infect Dis Clin North Am (1997) 0.98

Urinary tract pathogens in complicated infection and in elderly individuals. J Infect Dis (2001) 0.98

Epidemiology and risk factors for urinary tract infection following spinal cord injury. Arch Phys Med Rehabil (1993) 0.98

Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria. Rev Infect Dis (1986) 0.97

Randomized trial of meatal care with silver sulfadiazine cream for the prevention of catheter-associated bacteriuria. J Infect Dis (1992) 0.97

Treatment of complicated urinary tract infections with lomefloxacin compared with that with trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother (1994) 0.96

Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med (1999) 0.96

Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study. Antimicrob Agents Chemother (2002) 0.96

Perioperative antibiotic prophylaxis in urology. Curr Opin Urol (2001) 0.95

Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections. Int J Antimicrob Agents (2002) 0.95

The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients. Arch Intern Med (2000) 0.95

Urinary tract infections following renal transplantation. Clin Transplant (1998) 0.93

A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients. Clin Infect Dis (1995) 0.93

Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study. Antimicrob Agents Chemother (1991) 0.93

Serum and urine concentrations of cefoperazone in severe chronic renal failure. Drugs (1981) 0.92

The treatment of Pseudomonas aeruginosa urinary tract infections with norfloxacin. J Antimicrob Chemother (1984) 0.92

Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up. Scand J Infect Dis (2003) 0.91

Autonomic dysreflexia and its urological implications: a review. J Urol (1991) 0.91

Urinary tract infections in patients with severe renal disease. Treatment with ampicillin and trimethoprim-sulfamethoxazole. JAMA (1976) 0.89

Role of bacterial infection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil (1996) 0.89

Ciprofloxacin therapy in complicated urinary tract infections caused by Pseudomonas aeruginosa and other resistant bacteria. J Antimicrob Chemother (1986) 0.89

Bacterial colonization of ureteral stents. Eur Urol (1999) 0.88

A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults. Urology (2002) 0.88

Molecular typing and fluconazole susceptibility of urinary Candida glabrata isolates from hospitalized patients. Diagn Microbiol Infect Dis (1997) 0.88

Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol (2000) 0.87

Do antimicrobials have a role in preventing septicaemia following instrumentation of the urinary tract? J Hosp Infect (2000) 0.87

A practical guide to antimicrobial management of complicated urinary tract infection. Drugs Aging (2001) 0.87

Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections. Urol Int (2005) 0.87

Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections. Am J Med (1989) 0.86

Does the addition of disinfectant to urine drainage bags prevent infection in catheterised patients? Lancet (1983) 0.86

Bacteriuria in patients treated with clean intermittent catheterization. Scand J Infect Dis (1991) 0.86

Evaluation of cranberry supplement for reduction of urinary tract infections in individuals with neurogenic bladders secondary to spinal cord injury. A prospective, double-blinded, placebo-controlled, crossover study. J Spinal Cord Med (2004) 0.86

Short-term versus prolonged systemic antibiotic prophylaxis in patients treated with indwelling catheters. J Urol (1985) 0.85

Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection. J Antimicrob Chemother (1996) 0.85

Norfloxacin treatment in complicated urinary tract infection. Scand J Infect Dis Suppl (1986) 0.85

Piperacillin/tazobactam in complicated urinary tract infections. Intensive Care Med (1994) 0.85

Comparison of netilmicin with cefoperazone for the treatment of severe or complicated urinary tract infections. Aust N Z J Med (1985) 0.84

Urinary tract infection in patients with urological complications after renal transplantation with respect to long-term function and allograft survival. Ann Transplant (2001) 0.84

Prophylactic methenamine hippurate or nitrofurantoin in patients with an indwelling urinary catheter. Ann Clin Res (1981) 0.84

Randomized, double-blind comparison of ceftazidime and moxalactam in complicated urinary tract infections. Antimicrob Agents Chemother (1985) 0.84

Accuracy of rapid urine screening tests among incontinent nursing home residents with asymptomatic bacteriuria. J Am Geriatr Soc (1995) 0.84

Impact of a urinary tract infection educational program in persons with spinal cord injury. J Spinal Cord Med (2004) 0.84

Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment. Infection (1974) 0.83

Epidemiologic and diagnostic aspects of bacteriuria: a longitudinal study in older women. J Am Geriatr Soc (1995) 0.83

A sequential study of intravenous and oral Fleroxacin for 7 or 14 days in the treatment of complicated urinary tract infections. Int J Antimicrob Agents (1995) 0.82

Bacteriuria and bacteraemia in patients with long-term indwelling catheters--a domiciliary study. J Med Microbiol (1988) 0.81

Low risk of bacteremia during catheter replacement in patients with long-term urinary catheters. Arch Intern Med (1997) 0.81

Antiinfective and encrustation-inhibiting materials--myth and facts. Int J Antimicrob Agents (2002) 0.81

Outcome following antimicrobial therapy for asymptomatic bacteriuria in elderly women resident in an institution. Age Ageing (1988) 0.81

Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J Urol (2004) 0.80

Bacteriuria in women with long-term catheters: paired comparison of indwelling and replacement catheters. J Infect Dis (1988) 0.80

Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection. Antimicrob Agents Chemother (1988) 0.80

A multicenter, double-blind, trimethoprim-sulfamethoxazole controlled study of enoxacin in the treatment of patients with complicated urinary tract infections. J Urol (1989) 0.79

A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis. Clin Ther (2002) 0.79

Evaluation of specific systemic antimicrobial therapy in patients while on closed catheter drainage. J Urol (1968) 0.79

Comparison of enoxacin versus trimethoprim-sulfamethoxazole in the treatment of patients with complicated urinary tract infection. Clin Ther (1995) 0.79

Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women. Eur J Clin Microbiol Infect Dis (2000) 0.78

Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections. Int J Antimicrob Agents (2004) 0.78

Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study. J Chemother (1996) 0.78

Articles by these authors

Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin Infect Dis (1997) 2.65

Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med (1987) 2.48

Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol (2001) 2.45

Definitions of infection for surveillance in long-term care facilities. Am J Infect Control (1991) 2.33

Bacteriuria in elderly institutionalized men. N Engl J Med (1983) 2.20

The association of urinary tract infection with sexual intercourse. J Infect Dis (1982) 2.05

Infectious diseases as a Canadian subspecialty, with projections to the year 2000. Rev Infect Dis (1990) 1.99

Characterization of coagulase-negative staphylococci from urinary tract specimens. J Clin Microbiol (1983) 1.81

Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents (2001) 1.51

Febrile urinary infection in the institutionalized elderly. Am J Med (1996) 1.47

Use of Antimicrobials during Pregnancy. Can Fam Physician (1987) 1.41

Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. The Manitoba Diabetic Urinary Infection Study Group. Clin Infect Dis (1995) 1.27

Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society. CMAJ (1999) 1.24

Asymptomatic bacteriuria--important or not? N Engl J Med (2000) 1.24

The association of bacteriuria with resident characteristics and survival in elderly institutionalized men. Ann Intern Med (1987) 1.24

Development of multiple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones. Antimicrob Agents Chemother (1995) 1.17

Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population. J Med Virol (1982) 1.17

How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study. Ann Intern Med (1991) 1.15

Prevalence of antibody to hepatitis A virus in a Canadian Inuit community. Can Med Assoc J (1982) 1.10

Prospective study of decubitus ulcers in two long term care facilities. Can J Infect Control (1994) 1.08

Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Canadian Infectious Diseases Society Clinical Trials Study Group. Arch Intern Med (1992) 1.08

Twelve-month surveillance of infections in institutionalized elderly men. J Am Geriatr Soc (1984) 1.08

Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly. Clin Infect Dis (1996) 1.07

Prospective, randomized, comparative trials in the therapy for intraabdominal and female genital tract infections. Rev Infect Dis (1984) 1.04

Management of complicated urinary tract infection in older patients. J Am Geriatr Soc (1996) 1.03

An outbreak of methicillin resistant Staphylococcus aureus on a burn unit: potential role of contaminated hydrotherapy equipment. Burns (2001) 1.00

Susceptibility of clinical isolates of Staphylococcus saprophyticus to fifteen commonly used antimicrobial agents. Antimicrob Agents Chemother (1982) 1.00

Salmonella urinary tract infections associated with exposure to pet iguanas. Clin Infect Dis (1997) 0.98

Haemophilus influenzae meningitis in Manitoba and the Keewatin District, NWT: potential for mass vaccination. CMAJ (1988) 0.96

The changing epidemiology of hepatitis B virus infection in the Canadian north. Am J Epidemiol (1985) 0.95

The impact of postdischarge infection on surgical wound infection rates. Infect Control (1987) 0.94

Emergence of rifampin-resistant Haemophilus influenzae. Antimicrob Agents Chemother (1982) 0.94

A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia. J Antimicrob Chemother (1983) 0.94

Long-term antimicrobial prophylaxis for recurrent urinary tract infection in women. Rev Infect Dis (1982) 0.92

Serological evidence of hepatitis E virus infection in an indigenous North American population. Can J Gastroenterol (2007) 0.91

A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumonia. J Antimicrob Chemother (1987) 0.91

Chronic prosthetic device infection with Francisella tularensis. Clin Infect Dis (1999) 0.88

Asymptomatic bacteriuria in diabetic women. Diabetes Care (2000) 0.88

Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol (2000) 0.87

Significance of pharyngeal colonization with aerobic gram-negative bacilli in elderly institutionalized men. Age Ageing (1986) 0.86

Klebsiella pneumoniae infection on a rehabilitation unit: comparison of epidemiologic typing methods. Infect Control Hosp Epidemiol (1993) 0.86

Asymptomatic bacteriuria in patients with diabetes mellitus. Rev Infect Dis (1991) 0.85

Efficacy of mupirocin nasal ointment in eradicating Staphylococcus aureus nasal carriage in chronic haemodialysis patients. J Hosp Infect (1991) 0.83

Sequential antibiotic therapy: Effective cost management and patient care. Can J Infect Dis (1995) 0.83

Nosocomial pneumonia in a Canadian tertiary care center: a prospective surveillance study. Infect Control Hosp Epidemiol (1991) 0.83

Low prevalence of VRE gastrointestinal colonization of hospitalized patients in Manitoba tertiary care and community hospitals. Can J Infect Dis (2000) 0.82

Nursing home dilemmas. Infect Control Hosp Epidemiol (1997) 0.81

Low prevalence of gastrointestinal colonization with antimicrobial-resistant bacteria in high risk units in a Canadian tertiary care centre. Can J Infect Dis (1996) 0.81

Cross-sectional seroepidemiologic study of the prevalence of cytomegalovirus and herpes simplex virus infection in a Canadian Inuit (Eskimo) community. Scand J Infect Dis (1986) 0.81

Standards of therapy for urinary tract infections in adults. Infection (1992) 0.81

Chemoprophylaxis for Neisseria meningitidis in an isolated Arctic community. J Infect Dis (1982) 0.81

Frequency of changing enteral alimentation bags and tubing, and adverse clinical outcomes in patients in a long term care facility. Can J Infect Control (1993) 0.81

Asymptomatic bacteriuria in spinal cord patients and the elderly. Urol Clin North Am (1999) 0.80

Urine cultures and long-term indwelling catheters. Arch Intern Med (1985) 0.80

High prevalence of antibodies to Chlamydia trachomatis in a Northern Canadian community. Can J Public Health (1983) 0.79

Varicella zoster virus and multiple sclerosis in a Hutterite population. J Clin Epidemiol (1995) 0.79

Nosocomial pneumonia on general medical and surgical wards in a tertiary-care hospital. Infect Control Hosp Epidemiol (1997) 0.79

The varicella zoster virus: a pilot trial of a potential therapeutic agent in multiple sclerosis. J Clin Epidemiol (1997) 0.78

Effect of subinhibitory antimicrobial concentrations (sub-MICs) on in-vitro bacterial adherence to uroepithelial cells. J Antimicrob Chemother (1992) 0.78

Group A streptococcal pharyngeal carriage and impetigo in two northern native communities. Arctic Med Res (1988) 0.77

Conjunctivitis in a long-term care facility. Infect Control Hosp Epidemiol (1995) 0.77

Surgical wound infection and cancer among the elderly: a case control study. J Surg Oncol (1990) 0.77

Effect of subinhibitory concentrations of Ciprofloxacin and gentamicin on the adherence of Pseudomonas aeruginosa to Vero cells and voided uroepithelial cells. Chemotherapy (1993) 0.77

Genital herpes and hepatitis in healthy young adults. J Med Virol (1986) 0.76

Pseudo-outbreak of blastomycosis associated with contaminated bronchoscopes. Infect Control Hosp Epidemiol (1992) 0.76

Adherence of Escherichia coli to epithelial cells in the pathogenesis of urinary tract infection. Clin Invest Med (1985) 0.75

Vaginal infections. Can Fam Physician (1989) 0.75

Candida albicans epididymo-orchitis and fungemia in a patient with chronic myelogenous leukemia. Can J Infect Dis (1996) 0.75

Varicella zoster antibodies after herpes zoster, varicella and multiple sclerosis. Can J Neurol Sci (1997) 0.75

Ciprofloxacin or imipenem use correlates with resistance in Pseudomonas aeruginosa. Can J Infect Dis (1998) 0.75

Antimicrobial resistance: The never ending story. Can J Infect Dis (1991) 0.75

Viruses without borders. Can J Infect Dis (2000) 0.75

Antibody response in seropositive multiple sclerosis patients vaccinated with attenuated live varicella zoster virus. Can J Infect Dis (1996) 0.75

An Id reaction to Mycobacterium leprae: first documented case. Cutis (1994) 0.75

Forum: surveillance of surgical site infections. Asepsis (1994) 0.75

An outbreak of group A streptococcal bacteremia in an intensive care unit. Infect Control (1986) 0.75

Cefoxitin plus tobramycin and clindamycin plus tobramycin. A prospective randomized comparison in the therapy of mixed aerobic/anaerobic infections. Arch Surg (1986) 0.75

The impact of postdischarge infection on surgical wounds. Todays OR Nurse (1987) 0.75

Hepatitis B and Epstein-Barr virus serology in the Canadian Inuit. Arctic Med Res (1988) 0.75

Antimicrobial agents. Phys Med Rehabil Clin N Am (1999) 0.75

Single dose treatment failure in women with acute cystitis. Infection (1992) 0.75

Nosocomial infections on nursing units with floors cleaned with a disinfectant compared with detergent. J Hosp Infect (1987) 0.75

Asymptomatic bacteriuria in institutionalized elders in Israel. J Am Med Dir Assoc (2003) 0.75

A new society. Can J Infect Dis (2002) 0.75

Percutaneous feeding tube changes in long-term-care facility patients. Infect Control Hosp Epidemiol (1996) 0.75

Antimicrobial activity of subinhibitory concentrations of ciprofloxacin against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effect. Chemotherapy (1992) 0.75

Serological markers for Epstein-Barr virus infection in chronic carriers of hepatitis B surface antigen who live in northern Canada. J Infect Dis (1987) 0.75